Aixin Life International, which sells nutritional and wellness products in China, withdrew its plans for an initial public offering on Thursday. After originally filing in 2023 to raise $25 million, it slashed its offering to $7 million before raising it back to $10 million by offering 2.5 million shares at $4.
The Chengdu, China-based company was founded in 2001 and booked $4 million in revenue for the 12 months ended September 30, 2024. It had planned to list on the Nasdaq under the symbol AIXN. Boustead Securities was set to be the sole bookrunner on the deal.
